Lates News

Weight loss drug manufacturer Kailera Therapeutics made its debut on the Nasdaq on Friday, with its stock price opening at $26, a significant increase of 62.5% from its initial public offering price of $16 per share. The intraday increase was maintained at around 57%, pushing the market value of the company past $2 billion. The IPO raised $625 million, making it the largest IPO in the American biotech sector since 2021.